About AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals is a company based in Vienna (Austria) founded in 1996 was acquired by Elan in May 2013. AOP Orphan Pharmaceuticals operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Mereo BioPharma and Amicus Therapeutics, among others.
- Headquarter Vienna, Austria
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AOP Orphan Pharmaceuticals
Detailed funding history for AOP Orphan Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Elan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of OTC products, prescription pharmaceuticals, nutritional products, and APIs
|
Locked | Locked | Locked |
Investor details for AOP Orphan Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AOP Orphan Pharmaceuticals
Investment portfolio details for AOP Orphan Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AOP Orphan Pharmaceuticals
Detailed financials for AOP Orphan Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aop Orphan Pharmaceuticals Comparisons
Peer comparison for AOP Orphan Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Mereo BioPharma and Amicus Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for cancer and rare diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of therapies for rare and orphan diseases
|
|
| Locked | Locked | Locked |
Developer of therapeutics to treat rare genetic diseases
|
Detailed competitors of AOP Orphan Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aop Orphan Pharmaceuticals
Complete news archive for AOP Orphan Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals was founded in 1996.
AOP Orphan Pharmaceuticals is headquartered in Vienna, Austria.
Founded in 1996 in Vienna, Austria, the company focuses on the pharmaceutical sector, particularly orphan drugs for rare diseases. Research, development, production, and distribution of specialized products occur in areas such as hematology, oncology, cardio-pulmonology, neurology, psychiatry, and metabolicgenetic disorders. A product pipeline is maintained for upcoming therapies, including treatments for tachycardia and polycythemia vera. Operations span all five continents, with branch offices in core European and Middle Eastern markets.
AOP Orphan Pharmaceuticals's top competitors include Moderna, Spark Therapeutics and BridgeBio.
AOP Orphan Pharmaceuticals has 1 investor. Key investors include Elan.